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Edited by Stuart FergusonAbstract The polyketide synthase associated with the biosyn-
thesis of enediyne-containing calicheamicin contains a putative
phosphopantetheinyl transferase (PPTase) domain. By cloning
and expressing the C-terminal region of the polyketide synthase
and in vitro phosphopantetheinylation assay, we found that the
PPTase domain exhibits preferred substrate speciﬁcity towards
acyl and peptidyl carrier proteins in fatty acid and non-ribosomal
peptide synthesis over its cognate partner. We also found evi-
dence suggesting that the PPTase domain adopts a pseudo-tri-
meric structure, distinct from the pseudo-dimeric structure of
type II PPTases. The results revealed a novel type of PPTase
with unique structure and substrate speciﬁcity, and suggested
that the polyketide synthase probably acquired the PPTase do-
main from a primary metabolic pathway in evolution.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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4 0-Phosphopantetheinyl transferases (PPTase) are responsi-
ble for the post-translational modiﬁcation of carrier proteins
(CPs) in many primary and secondary metabolic pathways.
The CPs can be stand-alone proteins such as the bacterial acyl
carrier proteins (ACP) in fatty acid synthesis, or domains with-
in multifunctional proteins such as the ACP or peptidyl carrier
protein (PCP) domains in polyketide synthases (PKS) and
non-ribosomal peptide synthetase (NRPS) [1]. PPTases trans-
fer the phosphopantetheinyl group of co-substrate CoA to a
conserved serine residue in CPs. The modiﬁcation of CPs with
the ﬂexible phosphopantetheinyl group allows them to shuttle
acyl intermediates between proteins or domains through
reversible formation of a thioester linkage [2].Abbreviations: PPTase, phosphopantetheinyl transferase; CP, carrier
protein; ACP, acyl carrier protein; PCP, peptidyl carrier protein; PKS,
polyketide synthase; NRPS, non-ribosomal peptide synthase; FAS,
fatty acid synthase; AcpS, acyl carrier protein synthase; DACP, ACP
domain from the modular PKS DEBS; EACP, ACP from E. coli fatty
acid synthesis pathway; meACP, ACP domain of the iterative PKS in
calicheamicin biosynthesis (M. echinospora ssp.); GPCP, PCP domain
of non-ribosomal peptide synthase (GrsA B. brevis)
*Corresponding author. Fax: +65 67913856.
E-mail address: zxliang@ntu.edu.sg (Z.-X. Liang).
0014-5793/$34.00  2008 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2008.02.061PPTases are roughly categorized into three classes based on
overall protein structure and substrate speciﬁcity. The ﬁrst
class (type I) is represented by the homotrimeric acyl carrier
protein synthases (AcpS) in fatty acid synthesis from Esche-
richia coli and other bacteria. Each monomer of the AcpS pro-
teins contains about 120 residues and exhibits preferred
substrate speciﬁcity towards CPs from primary metabolic
pathways [3,4]. The second class (type II) is represented by
Sfp from Bacillus subtilis. The monomeric type II PPTases usu-
ally contain about 240 residues and exhibit diverse substrate
speciﬁcity towards various ACPs and PCPs. The monomeric
structure of type II PPTases is considered as pseudo-dimeric
because the two sub-domains resemble two AcpS monomers
[5]. The second class also includes PPTases with extended poly-
peptide chains that contain as many as 329 and 309 residues
for human PPTase and Lys5 [6,7]. The third class (type III)
is the integrated PPTase domains contained in fungal and
yeast fatty acid synthases (FAS) [8,9]. The type III PPTase do-
mains contain 140 residues and are structurally similar to
type I PPTases. The substrate speciﬁcity for this class of PPTa-
ses has not been characterized due to the inactivity of the re-
combinant PPTase domain protein [10].
Enediyne natural products, such as calicheamicin, are a fam-
ily of natural products characterized by the unique 9- or 10-
member enediyne moiety and potent antitumor activity
(Fig. 1a) [11]. The biosynthesis of the enediyne moiety is car-
ried out by an iterative PKS and other accessory enzymes
[12]. Deduced from protein sequence, the iterative PKS for
the biosynthesis of the 10-membered enediyne-containing cali-
cheamicin in Micromonospora echinospora ssp. calichensis con-
tains at least ﬁve domains for assembling an unknown
precursor of the enediyne moiety (Fig. 1b). The ﬁve domains
include the typical ketosynthase (KS), acyl transferase (AT),
dehydratase (DH), ketoreductase (KR) and ACP domains
[13]. The identiﬁcation of the ACP domain was to some extent
speculative given the low sequence homology shared with
other CPs and the lack of a signature motif conserved in many
CPs. In addition, the iterative PKS contains about 330 resi-
dues at the C-terminus that do not share signiﬁcant homology
with any characterized proteins. A portion of the C-terminus
(1707–1919 aa) was suggested to be an Sfp-like PPTase domain
since most catalytic residues for Mg2+ and CoA binding in
type II PPTases can be identiﬁed in the protein sequence de-
spite the overall low sequence homology [13]. The assignment
of the PPTase domain would imply that the PKS can undergo
self-phosphopantetheinylation without the assistance of other
external PPTases. The integration of PPTase domain in PKSblished by Elsevier B.V. All rights reserved.
Fig. 1. (a) Structure of the 10-membered enediyne-containing calicheamicin produced byMicromonospora echinospora ssp. calichensis. (b) Proposed
domain composition of the PKS (encoded by gene CalE8) for enediyne biosynthesis. (KS: ketosynthase domain; AT: acyltransferase domain; ACP:
acyl carrier protein domain; KR: Ketoreductase domain; DH: dehydratase domain).
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are usually stand-alone proteins [14]. By cloning and express-
ing the C-terminal region of the PKS in calicheamicin biosyn-
thesis, we found evidence suggesting that the PPTase domain
in enediyne biosynthesis represents a novel type of PPTase
with unique overall structure and substrate speciﬁcity. These
results presented here also provide insight into the evolution-
ary origin of the integrated PPTase domain.2. Materials and methods
2.1. Materials
Coenzyme A and other chemicals were purchased from Sigma.
Restriction enzymes and other molecular biology reagents were pur-
chased from New England BioLabs and other commercial sources.
Custom synthesized EACP, DACP and GPCP genes were obtained
from GenScript Corporation (NJ, USA).
2.2. Protein cloning, expression and puriﬁcation
The DNA fragments that encode meACP (2773–3051 bp), PPTase1
(5119–5757 bp), PPTase2 (4918–5757 bp) and PPTase3 (4771–5757 bp)
were ampliﬁed from the synthesized PKS gene based on the sequence
of CalE8 inM. echinospora (Kong et al. in preparation for publication)
[12]. PCR ampliﬁcation was carried out using DynazymeEXT (Finn-
zymes) and the PCR products were ligated into pET-28b(+) (Novagen)
between the NdeI and XhoI sites. The plasmids were transformed into
the E. coli strain BL21(DE3) for protein expression after the validation
of DNA sequences. The genes encoding EACP (from E. coli), DACP
(from Saccharopolyspora erythraea) and GPCP (also GrsA-PCP, from
Bacillus brevis) were also cloned into pET-28b(+) before transforma-
tion into BL21(DE3). The plasmid that contains the Sfp-encoding gene
obtained from Dr. Walshs lab was transformed into BL21(DE3) as
well [15]. For protein expression, two or four liters of LB medium were
inoculated and induced with 0.5 mM IPTG at OD 0.6. After shaking
overnight at 16 C, the cells were harvested by centrifugation and
washed with lysis buﬀer (50 mM Tris (pH 8.0), 500 mMNaCl, 5% glyc-
erol, 0.1 mMDTT, 0.1 mM PMSF). The pellet was re-suspended in the
lysis buﬀer and passed through a microﬂuidizer twice. The lysate was
centrifuged at 20000 rpm for 45 min and the clear supernatant was
incubated with Ni2+-NTA resin for one hour at 4 C. After washing,the (His)6-tagged protein was eluted with an imidazole gradient (50–
500 mM). The puriﬁed carrier proteins and Sfp were concentrated
and dialyzed into the buﬀer that contains 50 mM Tris (pH 8.0),
100 mM NaCl and 5% glycerol for storage. PPTase1 and PPTase3
were further puriﬁed by size-exclusion chromatography with a Super-
dex-75 column and buﬀer that contains 50 mM Tris (pH 8.0), 5% glyc-
erol and NaCl of various concentrations (50, 100, 200 or 500 mM).
Final protein concentrations were measured using the Bradford meth-
od.
2.3. PPTase activity assay
The activity assays for PPTases (Sfp, PPTase1, and PPTase3) were
performed against diﬀerent carrier proteins (meACP, DACP, EACP
and GPCP) following established method using a HPLC system
(LC1200, Agilent) [16]. Brieﬂy, the reaction mixture contains
50 lM carrier protein, 1 mM CoA, 15 mM MgCl2 and 10 lM
PPTase in the assay buﬀer (50 mM Tris, 100 mM NaCl, 5% glycerol).
For each reaction, a control reaction without CoA was carried out in
parallel. The reactions for Sfp were carried out at pH 7.0 and reactions
for PPTase1 and PPTase3 were carried out at their optimal pH of 8.8
as determined by pH screening. The reactions were incubated at 37 C
ranging from 15 min to 120 min. After stopping the reaction, 20 ll of
the reaction mixture was loaded onto an analytical C8-300SB Zorbax
column (Agilent) equilibrated with 0.05% TFA in HPLC-grade H2O.
By monitoring 220 nm absorbance, the apo- and holo-CPs were eluted
with a linear CH3CN gradient (20–90%) at the ﬂow rate of 1 ml/min.
The molecular weight of the apo-meACP was determined by MALDI
mass spectrometry.3. Results
We began by ﬁrst validating the role of the ACP domain, the
cognate partner of the putative PPTase domain. The bound-
aries of the ACP domain were initially deﬁned by Zazopoulos
et al. [13], but the expression of the 216 bp gene fragment failed
to produce any recombinant protein. After re-deﬁning the
boundaries by examining the PKS sequence as well as the pre-
dicted secondary structure, we were able to express the free-
standing ACP domain (meACP) containing 92 residues (925–
1016 aa) in high yield. The puriﬁed meACP is not phospho-
Fig. 2. In vitro modiﬁcation of CPs by Sfp. (a) HPLC chromatograms
of meACP after the incubation with Sfp in the presence (dash line) and
absence (solid line) of CoA. (b) Relative turnover of apo-CPs to holo-
CPs as catalyzed by Sfp. (Reaction conditions: 50 mM Tris–Cl, pH 7.0,
100 mM NaCl, 5% glycerol, 15 mMMg2+, 1 mM CoA, 37 C, 60 min).
Fig. 3. In vitro modiﬁcation of CPs by PPTase3. HPLC chromato-
grams of CPs after the incubation with PPTase3 in the presence (dash
line) and absence (solid line) of CoA. (Reaction conditions: 50 mM
Tris–Cl, pH 7.0, 100 mM NaCl, 5% glycerol, 15 mM Mg2+, 1 mM
CoA, 37 C, 60 min).
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apo-form (11451.85 Da) detected by mass spectrometry. We
utilized Sfp, the type II PPTase from B. subtilis with broad sub-
strate speciﬁcity, to test whether meACP can undergo phospho-
pantetheinylation. Under the experimental conditions, we
readily observed the formation of holo-meACP after the incu-
bation with Sfp and CoA for 1 h (Fig. 2a), with the overall turn-
over increasing slightly with extended incubation time. The
result conﬁrms the identity of the putative ACP domain despite
its low sequence homology shared with other CPs. To compare
with other CPs, we prepared three CPs that represent diﬀerent
families of CPs, including EACP from the fatty acid synthesis
pathway in E. coli, GPCP (or GrsA-PCP) from an NRPS in
B. brevis, and DACP from the modular PKS DEBS (module
2) in S. erythraea [17,18]. The three CPs were also expressed
in E. colimainly as apo-proteins and modiﬁed by Sfp with vary-
ing eﬃciency (Fig. 2b). Under the experimental conditions, the
eﬃciency for meACP modiﬁcation is comparable to that of
DACP and slightly higher than that of GPCP. Although the
relative eﬃciency for the modiﬁcation of DACP, meACP and
GPCP varies slightly with assay conditions such as pH and
incubation time, we consistently observed much faster modiﬁ-
cation of EACP by Sfp as indicated by the near complete turn-
over within 30 min. The observations seem to suggest that
meACP resembles DACP and GPCPmore than the EACP pro-
tein from primary metabolic pathway.After conﬁrming the role of meACP, we turned to examine
the modiﬁcation of meACP by its cognate partner, the putative
C-terminal PPTase domain. The domain boundaries (1707–
1919 aa) for the PPTase domain were initially determined by
sequence alignment with type II PPTases [19,20]. The puriﬁed
PPTase domain protein contains 213 residues and is referred as
PPTase1 (Fig. 1). Size-exclusion chromatography revealed that
PPTase1 mainly exists as a high-molecular-weight oligomer in
50 mM Tris (pH 8.0) with 100 mM NaCl and 5% glycerol. The
incubation of PPTase1 and the four CPs separately in the pres-
ence of Mg2+ and CoA did not yield holo-CPs under the same
conditions for Sfp activity assay. Extensive screening of buﬀer
conditions with high protein concentration and extended incu-
bation time still failed to generate any detectable holo forms.
Given the observation that PPTase1 mainly exists as a high-
molecular-weight oligomer, we reasoned that the inactivity
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observed for the free-standing C-terminal type III PPTase do-
main from yeast fatty acid synthase [10]. The assignment of the
PPTase domain boundaries based on sequence comparison left
110 residues between the DH domain and the putative PPTase
domain (PPTase1) with unknown function. In an eﬀort to ob-
tain active PPTase, we cloned two more proteins with one cov-
ering the sequence 1640–1919 aa (referred as PPTase2) and the
other covering the sequence 1591–1919 aa (referred as
PPTase3) (Fig. 1). PPTase2 contains the putative PPTase do-
main and half of the upstream linker region, while PPTase3
contains the putative PPTase domain and the whole linker re-
gion. The (His)6-tagged PPTase2 (31.0 kDa) and PPTase3
(35.7 kDa) were both over-expressed in E. coli in high yield.
However, while PPTase3 was found in soluble fraction and
readily puriﬁed by Ni2+ aﬃnity chromatography, PPTase2
was expressed mainly as insoluble inclusion body that prohibits
further study. Size-exclusion chromatography showed that the
majority of PPTase3 also exists as a high-molecular-weight oli-
gomer. The addition of 0.1% Tween and 20% glycerol in lysis
and puriﬁcation buﬀers did not change the oligomeric state.
The increase of salt concentration up to 500 mM gave rise to
a mixture of oligomers with diﬀerent molecular weight (data
not shown). No monomeric form of PPTase3 was observed
for all the buﬀer conditions we tested. Nonetheless, despite
the oligomerization, activity assays showed that PPTase3 is
an active PPTase that exhibits high and modest eﬃciency in
the modiﬁcation of EACP and GPCP, respectively (Fig. 3).
In contrast, PPTase3 seemed not able to modify meACP and
DACP under various assay conditions. The incapability of
PPTase3 in modifying meACP and DACP is surprising consid-
ering that meACP is its cognate ACP partner. The modiﬁcation
of meACP by PPTase3 was further examined under various
conditions. We could only observe a negligible amount of
holo-meACP even with very high enzyme concentration and
long incubation, suggesting extreme low catalytic eﬃciency of
PPTase3 for meACP.4. Discussion
Although the C-terminal placement of the PPTase domain in
enediyne PKSs bears a resemblance to the type III PPTase do-Fig. 4. Comparison of meACP with other carrier proteins. (a) Partial seque
modiﬁcation site Ser971 and conserved residues in the signature motif boxed.
DEBS; ACP:FAS1 (EACP) and ACP:FAS2 are from the fatty acid synthesis p
two aromatic PKSs in S. coelicolor and S. griseus; PCP1 (GPCP) and PCP2 a
synthesizing pathway of S. cerevisiae). (b) Phylogenetic relationship of meAmains in yeast/fungal FASs [8], identiﬁcation of catalytic resi-
dues conserved in type II PPTases suggested that the PPTase
domain is most likely a type II PPTase [13]. The integration
of PPTase domain into PKSs is rare and only the PPTase do-
main (SePptI) associated with erythromycin biosynthesis in S.
erythraea has been conﬁrmed to be a Sfp-like PPTase domain
with broad substrate speciﬁcity [14]. Several integrated PPTase
domains have also been deduced from protein sequences by
Copp and Neilan [21].
Since the putative ACP domain (meACP) in the enediyne
PKS not only shares very low sequence homology with other
CPs but also lacks the G and H/D residues in the signature
GX(H/D)S(L/I) motif conserved in many CPs (Fig. 4a), we be-
gan by ﬁrst validating the identity of the putative ACP domain
by using the promiscuous Sfp for in vitro phosphopantetheiny-
lation. The incubation of meACP and three representative CPs
with Sfp in the presence of CoA and Mg2+ led to the formation
of holo-CPs. The modiﬁcation eﬃciency for meACP is compa-
rable to those of DACP and GPCP but substantially lower
than that of EACP. The relative eﬃciency seemed to suggest
that meACP resembles the ACP or PCP domains from second-
ary metabolic pathways. The resemblance of meACP to PKS-
ACPs is further supported by phylogenetic analysis, which re-
vealed that meACP is evolutionarily close to modular PKS-
ACPs, rather than FAS-ACPs (Fig. 4b). Note that although
Sfp has been suggested to exhibit substrate preference towards
the CPs from secondary metabolic pathways [22], the higher
modiﬁcation eﬃciency for EACP in comparison to the three
CPs from secondary metabolic pathways probably reﬂects
the variation among diﬀerent FAS-ACPs. Indeed, very diﬀer-
ent catalytic eﬃciency has been observed for Sfp towards PCPs
from diﬀerent species, including tycc3-PCP from B. subtilis
(kcat = 96 min
1, kcat/Km = 22.6 min
1 lM1) and GPCP
(GrsA-PCP) from B. brevis (kcat = 10.3 min
1, kcat/
Km = 2.5 min
1 lM1) [23,24].
PPTase1 shares 18% sequence identity and 31% similarity
with Sfp and contains most of the catalytic residues for
Mg2+ and CoA binding for type II PPTases (Fig. 5c). How-
ever, PPTase1 is catalytically inactive and unable to modify
the four CPs. In contrast, PPTase3, the variant of PPTase1
that contains the entire upstream linker region exhibits PPTase
activity. The formation of high-molecular-weight oligomer for
PPTase1 and PPTase3 suggests that the diﬀerences in activitynce alignment of meACP and representative carrier proteins with the
(ACP:PKS1 (DACP) and ACP:PKS2 are from the module 2 and 5 of
athways of E. coli and B. subtilis; ACP:PKS3 and ACP:PKS4 are from
re from NRPSs of B. subtilis and B. brevis. ACP:lys2 is from the lysine
CP and representative carrier proteins.
Fig. 5. Comparison between PPTase3 and type I (AcpS from B. subtilis) and type II PPTases (Sfp from B. subtilis and human PPTase). (a) Schematic
illustration of the pseudo-trimeric structure of PPTase3 and the pseudo-dimeric structure of Sfp and human PPTase. (b) Sequence alignment of AcpS
(B. subtilis) and the linker region (1591–1706 aa). The conserved catalytic residues in type I PPTases are indicated by asterisk [25]. (c) Sequence
alignment of Sfp and the 1707–1919 aa region. The conserved catalytic residues in type II PPTases are indicated by asterisk.
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meric state. The lack of activity for PPTase1 indicates that
the linker region is critical for the function of the PPTase do-
main. Although it is unclear whether the linker region is di-
rectly involved in substrate binding and catalysis, it probably
plays a structural rather than catalytic role considering that
most putative catalytic residues are contained in the PPTase1
region based on sequence alignment with Sfp. This view is fur-
ther supported by the observation that PPTase2, the protein
that contains only about half of the linker region, is not able
to fold properly into a soluble protein. Unexpectedly, when
we aligned the sequences of PPTase3 and type II PPTases,
the linker region (116 aa) always aligned with the ﬁrst half
of the type II PPTases. Further sequence analysis also revealed
that the linker region shares sequence homology with type I
AcpS from B. subtilis (17% identity; 39% similarity) and S. coe-licolor (28% identity; 38% similarity) [4,25] (Fig. 5a). More
importantly, some of the catalytic residues in type I AcpS-like
proteins, including the residues for Mg2+ binding, subunit
interaction and 3 0,5 0-ADP stabilization [25], seem to be con-
served in the linker region (Fig. 5b). These observations led
us to propose that the intact PPTase domain includes the
whole C-terminal region (330 aa) and consists of three sub-
domains resembling the trimeric structure of AcpS-like type I
PPTases. Similar to the pseudo-dimeric structure of type II
PPTases, the structure of the PPTase domain can be consid-
ered as pseudo-trimeric with the three sub-domains sharing se-
quence homology with AcpS proteins. The identiﬁcation of the
conserved catalytic residues for type II PPTases from sequence
alignment indicates that the PPTase domain is likely to func-
tion like Sfp with only one active site for substrate binding
and catalysis.
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the cognate partner meACP by PPTase3 was surprising. Given
the substrate preference toward EACP and GPCP, it seems
that the PPTase domain resembles PcpS, a type II PPTase that
prefers FAS-ACPs and NRPS-PCPs [22]. Indeed, PPTase3
shares slightly higher sequence homology with PcpS (20%
identity; 32% similarity) than Sfp (18% identity; 31% similar-
ity), though the determinants of the substrate speciﬁcity are
not obvious from sequence comparison. The substrate speciﬁc-
ity of PPTase3 suggests that the PKS probably acquired the
PPTase domain from a primary metabolic pathway during
evolution. The extremely low eﬃciency in meACP modiﬁca-
tion also indicates that the PPTase domain has not evolved
to be an eﬃcient PPTase for modifying its cognate ACP do-
main. This is probably because there was little selective pres-
sure for the PPTase domain to improve its substrate
speciﬁcity towards the meACP domain, due to the low kinetic
barrier of self-phosphopantetheinylation within the PKS.
Although the in vitro activity assay did not clearly demon-
strate the modiﬁcation of meACP by PPTase3, in the study
of the full-length recombinant PKS for calicheamicin biosyn-
thesis, we found that the recombinant PKS is able to generate
a 15-carbon polyene product in the presence of acetyl CoA,
malonyl CoA and NADPH (Kong et al., in preparation for
publication). The production of the polyene conﬁrms the
occurrence of in vivo self-phosphopantetheinylation as well
as the function of the PPTase domain. (Note: After the sub-
mission of this manuscript, the activation of a homologous
PKS (SgcE) in 9-membered enediyne biosynthesis by self-phos-
phopantetheinylation was recently conﬁrmed by mass spec-
trometry [26].)
In summary, these results conﬁrm the C-terminal region
(330 aa) of the iterative PKS in enediyne biosynthesis as a
functional PPTase domain. The extremely low catalytic eﬃ-
ciency towards its own ACP partner and DACP indicates that
the PPTase domain has not evolved to eﬃciently phospho-
pantetheinylate the ACP domains from secondary metabolic
pathways. The results also suggested that the novel PPTase do-
main in enediyne biosynthesis probably diﬀers from typical
type II PPTases by adopting an unprecedented pseudo-trimeric
structure containing three AcpS-like sub-domains. These
observations support the viewpoint that the PPTase domain
originated from an AcpS-like ancestor and likely to have been
acquired by the PKS by a gene fusion event during evolution.
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